Federico Pessina1, Pierina Navarria2, Luca Cozzi2,3, Roberta Rudà4, Marco Conti Nibali5, Matteo Simonelli3,6, Francesco Costa5, Armando Santoro3,6, Elena Clerici2, Giulio Carta2, Marta Scorsetti2,3, Lorenzo Bello5,7. 1. Neurosurgical Oncology Department, Humanitas Cancer Center and Research Hospital, Rozzano (Milan), Italy. federico.pessina@humanitas.it. 2. Radiotherapy and Radiosurgery Department, Humanitas Cancer Center and Research Hospital, Rozzano, Italy. 3. Department of Biomedical Sciences, Humanitas University, Rozzano, Italy. 4. Consultant of Neurosurgical Oncology Department, Humanitas Cancer Center and Research Hospital, Rozzano, Italy. 5. Neurosurgical Oncology Department, Humanitas Cancer Center and Research Hospital, Rozzano (Milan), Italy. 6. Hematology and Oncology Department, Humanitas Cancer Center and Research Hospital, Rozzano, Italy. 7. University of Milan, Milan, Italy.
Abstract
ASTRACT: BACKGROUND: The incidence of glioblastoma among elderly patients is constantly increasing. The value of radiation therapy and concurrent/adjuvant chemotherapy has been widely assessed. So far, the role of surgery has not been thoroughly investigated. The study aimed to evaluate safety and impact of several entities of surgical resection on outcome of elderly patients with newly diagnosed glioblastoma treated by a multimodal approach. METHODS: Patients ≥ 65 years, underwent surgery were included. The extent of surgical resection (EOR) was defined as complete resection (CR = 100%), gross total resection (GTR = 90-99%), sub-total resection (STR = 78-90%), partial resection (PR = 30-78%), and biopsy. After surgery, all patients received adjuvant radiotherapy (60/2 Gy fraction) with concomitant/adjuvant temozolomide chemotherapy. RESULTS: From March 2004 to December 2015, 178 elderly with a median age of 71 years (range 65-83 years) were treated. CR was obtained in 8 (4.5%), GTR in 63 (35.4%), STR in 46 (25.8%), PR in 16 (9.0%), and biopsy in 45 (25.3%). RT was started in all patients, concurrent/adjuvant CHT in 149 (83.7%) and 132 (74.2%). The median follow-up time was 12.2 months (range 0.4-50.4 months). The median, 1- and 2-year progression-free survival was 8.9 months (95%CI 7.8-100 months), 32.0 ± 3.5%, and 12.9 ± 2.6%. The median, 1- and 2-year overall survival were 12.2 (95%CI 11.3-13.1 months), 51.1 ± 3.7%, and 16.3 ± 2.9%. Tumor location, extent of resection, and neurological status after surgery statistically affected survival (p ≪ 0.01). CONCLUSION: Maximal surgical resection is safe and feasible in elderly patients with influence on survival. A preoperative evaluation has to be carried out.
ASTRACT: BACKGROUND: The incidence of glioblastoma among elderly patients is constantly increasing. The value of radiation therapy and concurrent/adjuvant chemotherapy has been widely assessed. So far, the role of surgery has not been thoroughly investigated. The study aimed to evaluate safety and impact of several entities of surgical resection on outcome of elderly patients with newly diagnosed glioblastoma treated by a multimodal approach. METHODS:Patients ≥ 65 years, underwent surgery were included. The extent of surgical resection (EOR) was defined as complete resection (CR = 100%), gross total resection (GTR = 90-99%), sub-total resection (STR = 78-90%), partial resection (PR = 30-78%), and biopsy. After surgery, all patients received adjuvant radiotherapy (60/2 Gy fraction) with concomitant/adjuvant temozolomide chemotherapy. RESULTS: From March 2004 to December 2015, 178 elderly with a median age of 71 years (range 65-83 years) were treated. CR was obtained in 8 (4.5%), GTR in 63 (35.4%), STR in 46 (25.8%), PR in 16 (9.0%), and biopsy in 45 (25.3%). RT was started in all patients, concurrent/adjuvant CHT in 149 (83.7%) and 132 (74.2%). The median follow-up time was 12.2 months (range 0.4-50.4 months). The median, 1- and 2-year progression-free survival was 8.9 months (95%CI 7.8-100 months), 32.0 ± 3.5%, and 12.9 ± 2.6%. The median, 1- and 2-year overall survival were 12.2 (95%CI 11.3-13.1 months), 51.1 ± 3.7%, and 16.3 ± 2.9%. Tumor location, extent of resection, and neurological status after surgery statistically affected survival (p ≪ 0.01). CONCLUSION: Maximal surgical resection is safe and feasible in elderly patients with influence on survival. A preoperative evaluation has to be carried out.
Entities:
Keywords:
Elderly patients; Glioblastoma; Prognostic factors; Surgery
Authors: Francesco Bruno; Alessia Pellerino; Edoardo Pronello; Rosa Palmiero; Luca Bertero; Cristina Mantovani; Andrea Bianconi; Antonio Melcarne; Diego Garbossa; Roberta Rudà Journal: Brain Sci Date: 2022-05-11
Authors: Julia Klingenschmid; Aleksandrs Krigers; Johannes Kerschbaumer; Claudius Thomé; Daniel Pinggera; Christian F Freyschlag Journal: Front Oncol Date: 2022-05-26 Impact factor: 5.738
Authors: Ramin A Morshed; Jacob S Young; Megan Casey; Elaina J Wang; Manish K Aghi; Mitchel S Berger; Shawn L Hervey-Jumper Journal: World Neurosurg Date: 2022-02-15 Impact factor: 2.210
Authors: Matthew T Carr; Camille J Hochheimer; Andrew K Rock; Alper Dincer; Lakshmi Ravindra; Fan Lily Zhang; Charles F Opalak; Nora Poulos; Adam P Sima; William C Broaddus Journal: Sci Rep Date: 2019-12-27 Impact factor: 4.379